Dynamin inhibitory peptide, myristoylated (control)
Cat. No. 1776
Biological ActivityControl peptide version of dynamin inhibitory peptide, myristoylated (Cat. No. 1775), an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant effect on GABAA receptor-mediated miniature IPSPs.
(Modifications: Gln-1 = Myr-Gln, Arg-10 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Nong et al (2003) Glycine binding primes NMDA receptor internalization. Nature 422 302. PMID: 12646920.
Kittler et al (2000) Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J.Neurosci. 20 7972. PMID: 11050117.
Grabs et al (1997) The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J.Biol.Chem. 272 13419. PMID: 9148966.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Dynamin inhibitory peptide, myristoylated (control) from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Dynamin inhibitory peptide, myristoylated (control), supplier, 1775, Mitosis, Dynamin, Epac, GTPases, Tocris Bioscience, GTPase Inhibitor products